Fundamentals - AlphaKey Financial

Stock Fundamentals

Company Information

▼

Company Name

BioAge Labs, Inc

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

ISIN: US09077V1008

CIK: 0001709941

CUSIP: 09077V100

Currency: USD

Full Time Employees: 62

Phone: 510 806 1445

Website: https://bioagelabs.com

Fiscal Year End: December

IPO Date: Sep 26, 2024

Description:

BioAge Labs, Inc. is a biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. It also provides azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It develops BGE-102, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.

Address:

1445A South 50th Street, Richmond, CA, United States, 94804

Directors & Officers

▼

Name	Title	Year Born
Dr. Kristen Fortney Ph.D.	Co-Founder, CEO, President, Treasurer, Secretary & Director	1983
Dr. Eric Morgen M.D.	Co-Founder, COO & Director	1982
Dr. Paul D. Rubin M.D.	Chief Medical Officer & Executive VP of Research	1954
Dr. Dov A. Goldstein M.B.A., M.D.	Chief Financial Officer	1967
Mr. Rusty Montgomery Ph.D.	Senior Vice President of Research	NA
Ms. Julie Gammelgard	Senior Vice President of People	NA
Dr. Peng Leong M.B.A., Ph.D.	Chief Business Officer & Therapeutic Area Head of Brain Aging	NA
Mr. BJ Sullivan Ph.D.	Chief Strategy Officer	NA
Ms. Ann C. Neale RN BSN	Chief Development Officer	NA
Mr. Patrick Martin M.D.	Senior Vice President of Clinical Science	NA

Shares Statistics

▼

Shares Outstanding: 41.75M

Shares Float: 29.53M

% Insiders: 256.20%

% Institutions: 6,492.10%

Short % Float: 3.68%

Valuation Metrics

▼

Enterprise Value: $651.18M

Trailing P/E: 1.64

Forward P/E: 0.00

Financial Highlights

▼

Market Cap: $929.83M

EBITDA: $-89.53M

P/E Ratio: $1.64

Book Value: $7.74

Earnings/Share: $13.61

Profit Margin: 0.00%

Operating Margin: -1,126.58%

ROA (TTM): -17.46%

ROE (TTM): -25.64%

Revenue (TTM): $5.92M

Revenue/Share (TTM): $0.17

Earnings Growth (YOY): 0.00%

Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Date	EPS Actual	EPS Estimate	Difference	Surprise %
Mar 31, 2026	0.00	0.00	N/A	N/A
Dec 31, 2025	0.00	0.00	N/A	N/A
Sep 30, 2025	-0.56	-0.51	N/A	-901.30%
Jun 30, 2025	-0.60	-0.38	N/A	-5,731.52%
Mar 31, 2025	-0.36	-0.53	N/A	3,176.65%
Dec 31, 2024	-1.00	-0.66	N/A	-5,267.18%
Sep 30, 2024	-6.70	-0.73	N/A	-81,243.36%
Jun 30, 2024	-0.60	0.00	N/A	N/A

Balance Sheet (Yearly)

▼

Date	Cash	Total Debt	Total Assets	Total Liabilities	Total Equity
2024-12-31	$354.35M	$N/A	$358.23M	$35.11M	$323.13M
2023-12-31	$21.64M	$N/A	$25.92M	$199.32M	$-173.40M
2022-12-31	$27.64M	$N/A	$28.43M	$140.99M	$-112.56M
2017-12-31	$4.63M	$N/A	$69.51M	$47.66M	$21.85M
2016-12-31	$16.16M	$N/A	$161.33M	$112.84M	$48.49M
2015-12-31	$6.97M	$N/A	$143.09M	$96.73M	$46.36M
2014-12-31	$51.04M	$N/A	$152.44M	$94.91M	$57.53M
2013-12-31	$83.73M	$N/A	$114.08M	$49.07M	$65.01M

Financial Ratios

▼

Date	Current Ratio	Debt/Equity	Debt/Assets	Interest Coverage	Debt/EBITDA
2024-12-31	12.86x	0.03x	0.10x	-33.04x	-0.13x
2023-12-31	0.44x	-0.31x	7.69x	-6.21x	-0.95x
2022-12-31	4.78x	-0.02x	4.96x	-165.85x	-0.06x
2017-12-31	1.35x	0.23x	0.69x	N/A	-0.06x
2016-12-31	0.69x	0.48x	0.70x	N/A	-1.75x
2015-12-31	0.37x	0.22x	0.68x	N/A	-0.31x
2014-12-31	2.49x	0.05x	0.62x	N/A	-0.07x
2013-12-31	5.33x	0.10x	0.43x	-5.54x	-0.17x

Insider Trading

Date	Insider Name	Title	Transaction Type	Shares	Price	Value
Feb 02, 2026	Paul D Rubin	N/A	Sale	7.43K	$18.75	$139.37K
Jan 13, 2026	Dov A Md Goldstein	N/A	Sale	27.00K	$19.70	$531.90K
Jan 13, 2026	Kristen Fortney	N/A	Sale	233.11K	$18.12	$4.22M
Dec 09, 2025	Paul D Rubin	N/A	Sale	18.00K	$12.00	$216.00K
Dec 04, 2025	Paul D Rubin	N/A	Sale	68.90K	$10.19	$702.06K

📦 Raw API Data (JSON Explorer)

▼

Comprehensive raw data returned from the EOD Fundamentals API. Expand sections below to drill down.

Stock Fundamentals

Company Information

Directors & Officers

Shares Statistics

Valuation Metrics

Financial Highlights

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios (Yearly)

Financial Ratios (Quarterly)

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Insider Trading

📦 Raw API Data (JSON Explorer)

Watchlist

Assistant